| Issue Date | Title | Author(s) |
| 1 | Jul-2012 | Apoptotic effects of resveratrol, a grape polyphenol, on imatinib-sensitive and resistant K562 chronic myeloid leukemia cells | Can, Geylani; Çakır, Zeynep; Kartal, Melis; Gündüz, Ufuk; Baran, Yusuf |
| 2 | Jun-2010 | Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells | Baran, Yusuf ; Öztekin, Coşkun; Başsoy, Esen Yonca |
| 3 | 2012 | Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia | Baran, Yusuf ; Saydam, Güray |
| 4 | Jun-2009 | Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells | Güçlüler, Gözde; Baran, Yusuf |
| 5 | Mar-2011 | Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells | Can, Geylani; Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| 6 | 6-Dec-2011 | Imatinib-induced apoptosis: A possible link to topoisomerase enzyme inhibition | Baran, Yusuf ; Zencir, Sevil; Çakır, Zeynep; Öztürk, Esra; Topçu, Zeki |
| 7 | Apr-2013 | miR-17 in imatinib resistance and response to tyrosine kinase inhibitors in chronic myeloid leukemia cells | Fıratlıgil, Burcu ; Biray Avcı, Çığır; Baran, Yusuf |
| 8 | Feb-2016 | A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib | Kartal Yandım, Melis; Ceylan, Çağatay ; Elmas, Efe; Baran, Yusuf |
| 9 | Feb-2010 | Nilotinib significantly induces apoptosis in imatinib resistant K562 cells with wild-type BCR-ABL, as effectively as in parental sensitive counterparts | Ekiz, Hüseyin Atakan ; Can, Geylani; Gündüz, Ufuk; Baran, Yusuf |
| 10 | Apr-2013 | The roles of macromolecules in imatinib resistance of chronic myeloid leukemia cells by Fourier transform infrared spectroscopy | Baran, Yusuf ; Ceylan, Çağatay ; Camgöz, Aylin |
